GLP-1 drugs commonly cause nausea, constipation, or an uncomfortable sense of fullness, especially early on, because they slow digestion
These steps apply whether someone is currently on GLP-1 medication, tapering off, or recently discontinued
Zhao H, Zhang J, Cheng X, Nie X, He B (2023) Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment
5 and 4.8 vs
The main areas GLP-1 S is being studied for and the study-reported figures behind them
4.5.3 Risk communication: clarifying uncertainty Current evidence is insufficient to classify GLP-1RAs as relatively safe during pregnancy, and they should certainly not be used as a first-line treatment for gestational obesity or diabetes simply due to their weight-loss benefits (132)